Education
About Us
Working with TipRanks
Follow Us
Zoetis (ZTS)
NYSE:ZTS
ZTS Stock Chart & Stats
Day’s Range― - ―
52-Week Range$139.70 - $200.33
Previous CloseN/A
Volume625.10K
Average Volume (3M)2.73M
Market Cap
$70.23B
Enterprise Value$78.31B
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)28.8
Beta0.66
Next Earnings
Aug 12, 2025EPS Estimate
1.62Last Dividend Ex-Date
Apr 21, 2025Dividend Yield1.24%
Share Statistics
EPS (TTM)1.48
Shares Outstanding446,060,900
10 Day Avg. Volume2,595,575
30 Day Avg. Volume2,727,540
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap1.12
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda19.97
Forecast
1Y Price Target
$197.78Price Target Upside26.79% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
---
Bulls Say, Bears Say
Bulls Say
Financial PerformanceZoetis reported solid first quarter results with organic operational growth at 9%, exceeding expectations.
Growth PotentialExpectations of double-digit aggregate sales growth in parasiticides, dermatology, and OA pain mAbs appear achievable.
Market PositionZoetis is seen as a clear market leader in an industry with durable secular growth drivers.
Bears Say
Consumer TrendsManagement commentary highlighted that some premium products are experiencing small but notable consumer headwinds.
Product PerformanceLibrela US sales were slightly worse than expected, continuing a trend of disappointing results over multiple quarters.
Revenue DistributionProducts outside the top 20, which still account for about 30% of revenue, experienced a decline in sales.
---
Ownership Overview
0.07% Insiders
20.58% Mutual Funds
1.09% Other Institutional Investors
56.17% Public Companies and
Individual Investors
ZTS FAQ
What was Zoetis’s price range in the past 12 months?
Zoetis lowest stock price was $139.70 and its highest was $200.33 in the past 12 months.
What is Zoetis’s market cap?
Zoetis’s market cap is $70.23B.
When is Zoetis’s upcoming earnings report date?
Zoetis’s upcoming earnings report date is Aug 12, 2025 which is in 95 days.
How were Zoetis’s earnings last quarter?
Zoetis released its earnings results on May 06, 2025. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.409 by $0.071.
Is Zoetis overvalued?
According to Wall Street analysts Zoetis’s price is currently Undervalued.
Does Zoetis pay dividends?
Zoetis pays a Quarterly dividend of $0.5 which represents an annual dividend yield of 1.24%. See more information on Zoetis dividends here
What is Zoetis’s EPS estimate?
Zoetis’s EPS estimate is 1.62.
How many shares outstanding does Zoetis have?
Zoetis has 446,060,900 shares outstanding.
What happened to Zoetis’s price movement after its last earnings report?
Zoetis reported an EPS of $1.48 in its last earnings report, beating expectations of $1.409. Following the earnings report the stock price went down -5.182%.
Which hedge fund is a major shareholder of Zoetis?
Currently, no hedge funds are holding shares in ZTS
---
Zoetis Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$197.78 (26.79% Upside)
$197.78 (26.79% Upside)
Blogger Sentiment
Bullish
ZTS Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 212.2K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $260.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▲ 0.3%
Last 30 Days ▲ 0.3%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-8.67%
12-Months-Change
Fundamentals
Return on Equity
51.85%
Trailing 12-Months
Asset Growth
-0.34%
Trailing 12-Months
Company Description
Zoetis
Zoetis Inc. is a leading global animal health company dedicated to supporting veterinarians and livestock producers in improving the health and well-being of animals. Operating in the animal pharmaceuticals and diagnostics sectors, Zoetis provides a comprehensive portfolio of medicines, vaccines, diagnostic products, and services for both companion animals and livestock. The company's products are designed to prevent and treat diseases, enhance animal productivity, and ensure food safety.
---
ZTS Company Deck
---
ZTS Earnings Call
Q1 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a positive outlook for Zoetis, with strong growth in key segments and strategic resilience against macroeconomic challenges. While there are concerns around the slower adoption of Librela and tariff impacts, the overall market position remains robust with continued innovation and demand for their diverse portfolio.Read More>---
ZTS Revenue Breakdown
67.83% Companion animal
31.31% Livestock
0.86% Contract manufacturing & human health
---
ZTS Stock 12 Month Forecast
Average Price Target
$197.78
▲(26.79% Upside)
Technical Analysis
Dr Reddy's Laboratories
―
Viatris
―
Phibro Animal Health
―
HUTCHMED
―
Elanco Animal Health
―
---